体外膜氧合机市场份额，尺寸，趋势，行业分析报告，按组件（泵，氧气器，控制器，套管，配件）;通过模态（静脉动脉，静脉静脉，动脉静脉）;患者类型;通过申请;按地区;分部预测，2021 - 2028

报告摘要

The global extracorporeal membrane oxygenation (ECMO) machine market was valued at USD 202.1 million in 2020 and is expected to grow at a CAGR of 5.3% during the forecast period. Key drivers responsible for the market growth include rising cases of cardio-pulmonary disorders and respiratory problems across the globe.

了解有关此报告的更多信息：request for sample pages

根据疾病控制和预防中心公布的市场统计数据（CDC），在美国，单独的个体每37秒从此类心血管障碍中死亡。2018年，COPD是该国死亡原因之一。此外，通过医院采用体外膜氧合机服务的越来越大，加上了意识计划，也影响其增长。

根据卫生研究和质量的联邦机构，直到2018年，大约6890左右的体外膜氧合机程序在美国进行了。因此，由于这种因素，医疗机构的体外膜氧合机器的采用显着增加。乐动娱乐官网

Industry Dynamics

Growth Drivers
The recent spike in COVID-19 patients has boosted the adoption of extracorporeal membrane oxygenation machines. As per the statistics published by the Extracorporeal Life Support Organization (ELSO), in 2019, the number of hospitals offering extracorporeal membrane oxygenation services has risen to 264 and is currently used for the treatment of COVID-19 patients.

Moreover, increasing awareness about extracorporeal membrane oxygenation services, coupled with technological advancements is further projected to propel the market growth. Several individual governments are pledged to spread awareness about the benefits of extracorporeal membrane oxygenation services in the market.

For instance, an initiative such as Global Initiative for Chronic Obstructive Lung Disease (GOLD) is a dedicated organization engaged in creating positive awareness among COPD patients to use extracorporeal membrane oxygenation machines in the market.

Extracorporeal Membrane Oxygenation Machine Market Report Scope

市场主要是在组件，模态，患者类型，应用程序和地理区域的基础上进行分段。

由组件	通过方式	患者类型	通过申请	按地区
泵 氧气 控制器 套管 Accessories	静脉动脉 Veno-Venous 动脉静脉	新生儿 小儿科 成人	呼吸道 心脏 ECPR.	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

组件洞察力

The oxygenator market segment accounted for the largest revenue share of more than 34%, in 2020. Such high share is attributed to its high preference over other systems. Its high efficiency is due to acute exchange rate, primarily due to pump head thrombosis, mechanical failure, and acute oxygenator thrombosis.

泵体外膜氧合机市场段预计将在评估期内注册利润丰厚的增长率。市场上的市场增长是由于泵体外膜氧合机程序中的泵采用高，以及多种类型的泵，如叶轮和滚子的可用性。这些泵用于若干应用中，可以根据客户的要求定制。

Insight by Modality

基于模态，全球体外膜氧合机市场分为静脉动脉，静脉静脉和动脉静脉。2020年，静脉动脉市场分部占评估期间的大部分份额。这种高份额归因于其在治疗患有心脏病疾病的患者的高使用率。

Veno-venous market segment is projected to witness a lucrative growth rate over the assessment period. The adoption of extracorporeal membrane oxygenation services in the market segment is due to the rising incidence of COPD, across the globe. As per estimates of the WHO, in 2016, there were around 251 million cases of COPD and it is expected that number is expected to rise significantly in the coming years. Thus, the segment will exhibit a positive growth trajectory.

应用洞察力

基于应用，全球体外膜氧合机市场分为呼吸，心脏和ECPR。2020年，呼吸系统市场分部占评估期间的大部分份额。影响市场细分市场增长的主要司机包括呼吸系统疾病的普及和相关的病效。根据ELSO公开的统计数据，美国超过2,600人，遭受呼吸问题。

The cardiac surgery extracorporeal membrane oxygenation machine market segment is expected to register a lucrative growth rate over the study period. Rising cardiac surgeries and the use of extracorporeal membrane oxygenation machines in such surgeries likely to shape the segment’s future.

According to estimates of the American Heart Association, in 2016, around 1 in every 3 people in the U.S. die with cardiovascular disorder and it is expected that the direct medical cost of such heart-related ailments is projected to reach more than USD 749 million, by 2035.

Geographic Overview

北美体外膜肺氧合machine industry accounted for the majority of the share. Region’s market growth is attributed to the rising prevalence of target diseases such as COPD in both U.S. and Canada, the government’s commitment towards quality healthcare, the presence of key players with innovative solutions, and the high purchasing power capacity of hospitals.

此外，存在复杂的医疗保健基础设施，具有高可支配的患者收入导致了医院入学率的增加，乐动娱乐官网这反过来也有利于该地区的增长前景。

竞争洞察力

The prominent players operating in the extracorporeal membrane oxygenation machine industry are MAQUET Holding B.V., Medtronic plc, Nipro Medical Corporation, Sorin Group, Terumo Cardiovascular Systems, Medos Medizintechnik AG, and Microport Scientific.